Towards the identification of biomarkers of transplantation tolerance
- 1 July 2009
- journal article
- research article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 9 (7) , 521-526
Abstract
The identification of biomarkers of transplantation tolerance holds promise to improve the care of transplant recipients and advance our understanding of alloreactive immune responses. What progress has been made towards reaching this goal and what challenges remain? Although transplantation has been a standard medical practice for decades, the marked morbidity from the use of immunosuppressive drugs and poor long-term graft survival remain important limitations in the field. Achieving tolerance to transplanted organs should solve both problems, but has been an elusive goal. Recent advances in the human immunological toolbox have rekindled interest in studying the small number of transplant recipients who become tolerant to their grafts over time. The development of biomarkers of transplantation tolerance holds promise to improve the care of organ allograft recipients, to provide surrogate end points of tolerance induction strategies and to advance our understanding of the human immune response to both self and foreign antigens.Keywords
This publication has 42 references indexed in Scilit:
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progressionJournal of Clinical Investigation, 2008
- Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipientsJournal of Clinical Investigation, 2008
- Tolerance Versus Immunosuppression: A PerspectiveAmerican Journal of Transplantation, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in miceJournal of Clinical Investigation, 2007
- Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceProceedings of the National Academy of Sciences, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- ANALYSIS OF PRIMATE RENAL ALLOGRAFTS AFTER T-CELL DEPLETION WITH ANTI-CD3-CRM91,2Transplantation, 1998
- Isolation, phenotyping, and functional analysis of lymphocytes from human liverClinical Immunology and Immunopathology, 1990
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984